David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 26,000 shares at $80.38 ($2.1M) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market sale of $2.1M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.38 | 2,915 | $234K | 11.1% |
| 2 | $80.38 | 2,915 | $234K | 11.1% |
| 3 | $81.30 | 10,085 | $820K | 38.9% |
| 4 | $81.30 | 10,085 | $820K | 38.9% |
| Total | $81.09 avg | 26,000 | $2.1M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |